HK1077216A1 - Use of thiazole derivatives for the manufacture ofa medicament for the treatment of chronic obstruc tive pulmonary disease - Google Patents
Use of thiazole derivatives for the manufacture ofa medicament for the treatment of chronic obstruc tive pulmonary diseaseInfo
- Publication number
- HK1077216A1 HK1077216A1 HK05109340A HK05109340A HK1077216A1 HK 1077216 A1 HK1077216 A1 HK 1077216A1 HK 05109340 A HK05109340 A HK 05109340A HK 05109340 A HK05109340 A HK 05109340A HK 1077216 A1 HK1077216 A1 HK 1077216A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- treatment
- pulmonary disease
- thiazole derivatives
- manufacture ofa
- tive
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001222768 | 2001-07-24 | ||
PCT/JP2002/007221 WO2003009844A1 (fr) | 2001-07-24 | 2002-07-16 | Utilisation de derives de thiazole pour la fabrication d'un medicament pour le traitement de la bronchopneumopathie chronique obstructive |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1077216A1 true HK1077216A1 (en) | 2006-02-10 |
Family
ID=19056195
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK05109340A HK1077216A1 (en) | 2001-07-24 | 2005-10-20 | Use of thiazole derivatives for the manufacture ofa medicament for the treatment of chronic obstruc tive pulmonary disease |
Country Status (16)
Country | Link |
---|---|
US (2) | US20040147563A1 (fr) |
EP (1) | EP1411936B1 (fr) |
KR (1) | KR100566709B1 (fr) |
CN (1) | CN1267097C (fr) |
AR (2) | AR036179A1 (fr) |
AT (1) | ATE305299T1 (fr) |
BR (1) | BR0208719A (fr) |
CA (1) | CA2441804C (fr) |
DE (1) | DE60206391T2 (fr) |
DK (1) | DK1411936T3 (fr) |
ES (1) | ES2249596T3 (fr) |
HK (1) | HK1077216A1 (fr) |
MX (1) | MXPA04000620A (fr) |
MY (1) | MY128711A (fr) |
TW (1) | TWI302456B (fr) |
WO (1) | WO2003009844A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI394753B (zh) * | 2006-03-17 | 2013-05-01 | Otsuka Pharma Co Ltd | 新穎替妥牟拉(tetomilast)晶體 |
TW200815054A (en) * | 2006-06-19 | 2008-04-01 | Otsuka Pharma Co Ltd | Methods of using a thiazole derivative |
SG188852A1 (en) * | 2008-03-14 | 2013-04-30 | Otsuka Pharma Co Ltd | Mmp-2 and/or mmp-9 inhibitor |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69132944T2 (de) | 1990-11-30 | 2002-11-21 | Otsuka Pharmaceutical Co., Ltd. | Azolederivate als Inhibitor von Superoxide-Radikalen |
WO1998008830A1 (fr) * | 1996-08-26 | 1998-03-05 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Nouveaux derives de thiazol s'utilisant comme inhibiteurs selectifs de la pde-iv |
MY128323A (en) * | 1996-09-30 | 2007-01-31 | Otsuka Pharma Co Ltd | Thiazole derivatives for inhibition of cytokine production and of cell adhesion |
US6727364B2 (en) * | 2001-04-30 | 2004-04-27 | The Procter & Gamble Company | Triazole compounds useful in treating diseases associated with unwanted cytokine activity |
-
2002
- 2002-07-16 ES ES02746098T patent/ES2249596T3/es not_active Expired - Lifetime
- 2002-07-16 WO PCT/JP2002/007221 patent/WO2003009844A1/fr active IP Right Grant
- 2002-07-16 DK DK02746098T patent/DK1411936T3/da active
- 2002-07-16 MX MXPA04000620A patent/MXPA04000620A/es active IP Right Grant
- 2002-07-16 US US10/478,471 patent/US20040147563A1/en not_active Abandoned
- 2002-07-16 BR BR0208719-7A patent/BR0208719A/pt not_active Application Discontinuation
- 2002-07-16 CN CNB02807386XA patent/CN1267097C/zh not_active Expired - Fee Related
- 2002-07-16 KR KR1020037014359A patent/KR100566709B1/ko not_active IP Right Cessation
- 2002-07-16 DE DE60206391T patent/DE60206391T2/de not_active Expired - Lifetime
- 2002-07-16 EP EP02746098A patent/EP1411936B1/fr not_active Expired - Lifetime
- 2002-07-16 CA CA002441804A patent/CA2441804C/fr not_active Expired - Fee Related
- 2002-07-16 AT AT02746098T patent/ATE305299T1/de active
- 2002-07-18 AR ARP020102695A patent/AR036179A1/es not_active Application Discontinuation
- 2002-07-18 TW TW091116029A patent/TWI302456B/zh not_active IP Right Cessation
- 2002-07-19 MY MYPI20022737A patent/MY128711A/en unknown
-
2005
- 2005-10-20 HK HK05109340A patent/HK1077216A1/xx not_active IP Right Cessation
-
2007
- 2007-06-08 US US11/760,345 patent/US7932276B2/en not_active Expired - Fee Related
-
2013
- 2013-04-05 AR ARP130101121A patent/AR090619A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ATE305299T1 (de) | 2005-10-15 |
AR090619A2 (es) | 2014-11-26 |
CA2441804A1 (fr) | 2003-02-06 |
KR20040028749A (ko) | 2004-04-03 |
US20080081828A1 (en) | 2008-04-03 |
US7932276B2 (en) | 2011-04-26 |
EP1411936B1 (fr) | 2005-09-28 |
DK1411936T3 (da) | 2005-12-27 |
US20040147563A1 (en) | 2004-07-29 |
MY128711A (en) | 2007-02-28 |
KR100566709B1 (ko) | 2006-04-03 |
BR0208719A (pt) | 2004-07-20 |
DE60206391D1 (de) | 2006-02-09 |
TWI302456B (en) | 2008-11-01 |
CN1267097C (zh) | 2006-08-02 |
CA2441804C (fr) | 2007-05-08 |
ES2249596T3 (es) | 2006-04-01 |
CN1633295A (zh) | 2005-06-29 |
MXPA04000620A (es) | 2004-06-25 |
WO2003009844A1 (fr) | 2003-02-06 |
AR036179A1 (es) | 2004-08-18 |
EP1411936A1 (fr) | 2004-04-28 |
DE60206391T2 (de) | 2006-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS1400011I1 (hu) | Új gyógyszer krónikus elzáródásos tüdõbetegség kezelésére | |
CY2014019I1 (el) | Παραγωγα φαιναιθανολαμινης για θεραπεια ασθενειων του αναπνευστικου | |
NO20033594L (no) | Fenetanolamin-derivater for behandling av luftveissykdommer | |
HK1062408A1 (en) | Remedies for infant chronic arthritis-relating diseases | |
IL160884A0 (en) | Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease | |
IL159344A0 (en) | Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease | |
AU2003291992A1 (en) | Phenylethanolamine derivatives for the treatment of respiratory diseases | |
AU2003219690A1 (en) | Fused bicyclic-n-bridged-heteroaromatic carboxamides for the treatment of disease | |
AU2003279338A1 (en) | Phenethanolamine derivatives for the treatment of respiratory diseases | |
HK1087337A1 (en) | Use of a hif-alpha stabilizing agent for the preparation of medicament for treatment of diabetes | |
NO20043000L (no) | Et preparat for behandling av nevrocerebrovaskulaere sykdommer | |
ITMI20000312A0 (it) | Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva | |
IL213809A0 (en) | Use of derivatives of n-phenylpiperazin-1-yl-acetamide for the preparation of a pharmaceutical compositions for treatment of diabetes related conditions | |
PL375964A1 (en) | Use of indolyl derivatives for the manufacture of a medicament for the treatment allergic rhinitis | |
HUP0303988A2 (hu) | Azitromicin alkalmzása nem fertőző gyulladásos betegségek kezelésére szolgáló gyógyszerkészítmény előállítására | |
PT1487828E (pt) | Derivados de morfolinil-ureia para utilização no tratamento de doenças inflamatórias | |
IL143636A0 (en) | Diazepinoindoles for the treatment of chronic obstructive pulmonary disease | |
HK1077216A1 (en) | Use of thiazole derivatives for the manufacture ofa medicament for the treatment of chronic obstruc tive pulmonary disease | |
AU2003209542A8 (en) | Use of s-substituted l-crysteine for the manufacture of a medicament for the treatment of dermatological disorders | |
NO20025883L (no) | Tiazolidinonsalt for behandling av diabetes mellitus | |
GB0212790D0 (en) | Medicament for the treatment of diabetes | |
AU2002348105A1 (en) | Oral dosage forms for improving the bioavailability of therapeutic agents | |
HUP0402664A3 (en) | 2-indanylamino derivatives for the therapy of chronic pain | |
PL377524A1 (pl) | Zastosowanie substancji L-DOPA, jej pochodnych i zawierający te związki środek leczniczy do profilaktyki schorzeń psychotycznych | |
NO20042166L (no) | Kombinasjonsterapi for behandling av sykdom |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20160716 |